William A. Nuerge - Net Worth and Insider Trading
William A. Nuerge Net Worth
The estimated net worth of William A. Nuerge is at least $718,675 dollars as of 2024-04-25. William A. Nuerge is the Director of Supernus Pharmaceuticals Inc and owns about 23,750 shares of Supernus Pharmaceuticals Inc (SUPN) stock worth over $718,675. Details can be seen in William A. Nuerge's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that William A. Nuerge has not made any transactions after 2012-05-04 and currently still holds the listed stock(s).
Transaction Summary of William A. Nuerge
William A. Nuerge Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, William A. Nuerge owns 1 companies in total, including Supernus Pharmaceuticals Inc (SUPN) .
Click here to see the complete history of William A. Nuerge’s form 4 insider trades.
Insider Ownership Summary of William A. Nuerge
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SUPN | Supernus Pharmaceuticals Inc | 2014-01-21 | director |
William A. Nuerge Latest Holdings Summary
William A. Nuerge currently owns a total of 1 stock. William A. Nuerge owns 23,750 shares of Supernus Pharmaceuticals Inc (SUPN) as of May 4, 2012, with a value of $718,675.
Latest Holdings of William A. Nuerge
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SUPN | Supernus Pharmaceuticals Inc | 2012-05-04 | 23,750 | 30.26 | 718,675 |
Holding Weightings of William A. Nuerge
William A. Nuerge Form 4 Trading Tracker
According to the SEC Form 4 filings, William A. Nuerge has made a total of 0 transactions in Supernus Pharmaceuticals Inc (SUPN) over the past 5 years. The most-recent trade in Supernus Pharmaceuticals Inc is the acquisition of 15,000 shares on May 4, 2012, which cost William A. Nuerge around $75,000.
Insider Trading History of William A. Nuerge
- 1
William A. Nuerge Trading Performance
GuruFocus tracks the stock performance after each of William A. Nuerge's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by William A. Nuerge is 97.82%. GuruFocus also compares William A. Nuerge's trading performance to market benchmark return within the same time period. The performance of stocks bought by William A. Nuerge within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how William A. Nuerge's insider trading performs compared to the benchmark.
Performance of William A. Nuerge
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -16.25 | 97.82 | 93.47 | -13.74 | 15.81 | 30.44 |
| Relative Return to S&P 500(%) | -9.61 | 96.22 | 90.18 | -31.66 | -1.46 | 14.85 |
William A. Nuerge Ownership Network
Ownership Network List of William A. Nuerge
Ownership Network Relation of William A. Nuerge
William A. Nuerge Owned Company Details
What does Supernus Pharmaceuticals Inc do?
Who are the key executives at Supernus Pharmaceuticals Inc?
William A. Nuerge is the director of Supernus Pharmaceuticals Inc. Other key executives at Supernus Pharmaceuticals Inc include Sr. VP of IP & CSO Padmanabh P. Bhatt , Sr. V.P. & Regulatory Affairs Tami Tillotson Martin , and Sr VP & Quality & GMP Oper. & IT Frank Mottola .
Supernus Pharmaceuticals Inc (SUPN) Insider Trades Summary
Over the past 18 months, William A. Nuerge made no insider transaction in Supernus Pharmaceuticals Inc (SUPN). Other recent insider transactions involving Supernus Pharmaceuticals Inc (SUPN) include a net sale of 116,005 shares made by Padmanabh P. Bhatt , a net sale of 76,390 shares made by Jack A. Khattar , and a net sale of 21,235 shares made by Tami Tillotson Martin .
In summary, during the past 3 months, insiders sold 98,505 shares of Supernus Pharmaceuticals Inc (SUPN) in total and bought 0 shares, with a net sale of 98,505 shares. During the past 18 months, 231,113 shares of Supernus Pharmaceuticals Inc (SUPN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 231,113 shares.
Supernus Pharmaceuticals Inc (SUPN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Supernus Pharmaceuticals Inc Insider Transactions
William A. Nuerge Mailing Address
Above is the net worth, insider trading, and ownership report for William A. Nuerge. You might contact William A. Nuerge via mailing address: 842 Stephens Road, Independence Ky 41051.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
